We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Micropump Developed for Lab-On-A-Chip Disease Diagnosis

By LabMedica International staff writers
Posted on 18 Sep 2014
Print article
Image: An acoustically powered pumping device with 250 micron long oscillating structures driven by a piezoelectric transducer mounted on a glass slide shown next to US copper penny (Photo courtesy of Po-Hsun Huang and Tony Jun Huang).
Image: An acoustically powered pumping device with 250 micron long oscillating structures driven by a piezoelectric transducer mounted on a glass slide shown next to US copper penny (Photo courtesy of Po-Hsun Huang and Tony Jun Huang).
A reliable, inexpensive, programmable pump is a crucial feature for lab-on-a-chip devices that could make the diagnosis of many global life-threatening diseases easy and affordable.

An acoustofluidic pump powered by a piezoelectric transducer has been developed that utilizes the acoustic streaming effects generated by the oscillation of tilted sharp-edge structures.

Bioengineers and scientists at The Pennsylvania State University, (University Park, PA, USA) developed the pump which works by oscillating a series of thin sharp-edge structures hundreds of micrometers in length that have been constructed onto the sidewall of a microfluidic channel made of polydimethylsiloxane (PDMS), a widely used polymer. A miniaturized piezoelectric transducer, similar to the kind used in medical ultrasound, is the source of the oscillations.

The acoustofluidic pump was made by bonding a single-layer PDMS channel onto a single glass slide and attaching a piezoelectric transducer (Murata Electronics; Smyrna, GA, USA) adjacent to it using a thin layer of epoxy. To demonstrate the pumping behavior, the PDMS channel was designed to be a rectangular recirculating (in a counter-clockwise direction) channel composed of four portions: left channel, right channel, upper channel, and lower channel. The lower channel, referred to as the pumping region, was designed with 20 tilted sharp-edge structures on its sidewall, 10 on each side, while the other three channels were straight channels without any structures. The piezoelectric transducer, activated by amplified sine wave signals from a function generator (Tektronix; Beaverton, OR, USA) and an amplifier was used to acoustically oscillate the sharp-edge structures to generate acoustic streaming effects.

Tony Jun Huang, PhD, an engineering professor and senior author of the study, said, “Our pump is quite unique. It’s reliable and programmable, with a minimum of hardware, yet highly precise. The flow rates can be tuned across a wide range, from nanoliters per minute to microliters per minute. The permanent equipment for the total lab-on-a-chip system, including off-the-shelf electronics, could cost as little as about USD 25.00 to make, and the disposable chip could cost as little as USD 0.10. Although slightly more expensive than paper-based diagnostics, the system is far more versatile and precise, enabling quantitative analysis of, for example, human immunodeficiency virus (HIV), hepatitis, cancer, infectious diseases, cardiovascular diseases.” The study was published on September 4, 2014, in the journal Lab-on-a-chip.

Related Links:

The Pennsylvania State University
Murata Electronics 
Tektronix  


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A massive study has identified new biomarkers for renal cancer subtypes, improving diagnosis and treatment (Photo courtesy of Jessica Johnson)

Novel Biomarkers to Improve Diagnosis of Renal Cell Carcinoma Subtypes

Renal cell carcinomas (RCCs) are notably diverse, encompassing over 20 distinct subtypes and generally categorized into clear cell and non-clear cell types; around 20% of all RCCs fall into the non-clear... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more